Reshma Kewalramani - 19 Nov 2021 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Director
Signature
/s/ Karen Tepichin, Attorney-in-fact
Issuer symbol
DNA
Transactions as of
19 Nov 2021
Transactions value $
$0
Form type
4
Filing time
23 Nov 2021, 16:00:17
Previous filing
20 Sep 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Restricted Stock Units Award $0 +9.82K $0.00 9.82K 19 Nov 2021 Class A Common Stock 9.82K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Class A common stock.
F2 The RSUs vest on the day immediately prior to the Issuer's next annual meeting of shareholders and have no expiration date.